137 related articles for article (PubMed ID: 12507840)
1. Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece.
Petinaki E; Kontos F; Pratti A; Skulakis C; Maniatis AN
Int J Antimicrob Agents; 2003 Jan; 21(1):67-70. PubMed ID: 12507840
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
[TBL] [Abstract][Full Text] [Related]
3. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
[TBL] [Abstract][Full Text] [Related]
4. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.
Giovanetti E; Montanari MP; Mingoia M; Varaldo PE
Antimicrob Agents Chemother; 1999 Aug; 43(8):1935-40. PubMed ID: 10428916
[TBL] [Abstract][Full Text] [Related]
5. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
Billal DS; Hotomi M; Yamauchi K; Fujihara K; Tamura S; Kuki K; Sugita R; Endou M; Mukaigawa J; Yamanaka N
J Infect Chemother; 2004 Apr; 10(2):115-20. PubMed ID: 15160306
[TBL] [Abstract][Full Text] [Related]
6. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.
Hsueh PR; Teng LJ; Lee CM; Huang WK; Wu TL; Wan JH; Yang D; Shyr JM; Chuang YC; Yan JJ; Lu JJ; Wu JJ; Ko WC; Chang FY; Yang YC; Lau YJ; Liu YC; Leu HS; Liu CY; Luh KT;
Antimicrob Agents Chemother; 2003 Jul; 47(7):2152-7. PubMed ID: 12821461
[TBL] [Abstract][Full Text] [Related]
7. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
Tamayo J; Pérez-Trallero E; Gómez-Garcés JL; Alós JI;
J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
[TBL] [Abstract][Full Text] [Related]
8. [Resistance phenotypes and genotypes of Streptococcus pyogenes clinical isolates in Chile over a 10-year period].
Rodríguez C; Rojas P; Wozniak A; Kalergis AM; Cerón I; Riedel I; Román JC; Villarroel LA; Berríos X; Bavestrello L; García P
Rev Med Chil; 2011 Sep; 139(9):1143-9. PubMed ID: 22215392
[TBL] [Abstract][Full Text] [Related]
9. Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.
Katosova LK; Lazareva AV; Khokhlova TA; Ponomarenko OA; Alyabieva NM
Antibiot Khimioter; 2016 Aug; 61():23-29. PubMed ID: 29874449
[TBL] [Abstract][Full Text] [Related]
10. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
Hasenbein ME; Warner JE; Lambert KG; Cole SE; Onderdonk AB; McAdam AJ
J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women.
Pinheiro S; Radhouani H; Coelho C; Gonçalves A; Carvalho E; Carvalho JA; Ruiz-Larrea F; Torres C; Igrejas G; Poeta P
Microb Drug Resist; 2009 Jun; 15(2):121-4. PubMed ID: 19432524
[TBL] [Abstract][Full Text] [Related]
12. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
Bingen E; Bidet P; Mihaila-Amrouche L; Doit C; Forcet S; Brahimi N; Bouvet A; Cohen R
Antimicrob Agents Chemother; 2004 Sep; 48(9):3559-62. PubMed ID: 15328126
[TBL] [Abstract][Full Text] [Related]
13. Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.
Kataja J; Huovinen P; Skurnik M; Seppälä H
Antimicrob Agents Chemother; 1999 Jan; 43(1):48-52. PubMed ID: 9869564
[TBL] [Abstract][Full Text] [Related]
14. [Macrolide resistance phenotypes and genotypes in group G streptococci].
Açikgöz ZC; Göçer S; Almayanlar E
Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
[TBL] [Abstract][Full Text] [Related]
15. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.
Perez-Trallero E; Urbieta M; Montes M; Ayestaran I; Marimon JM
Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):25-31. PubMed ID: 9512178
[TBL] [Abstract][Full Text] [Related]
16. Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany.
Brandt CM; Honscha M; Truong ND; Holland R; Hövener B; Bryskier A; Lütticken R; Reinert RR
Microb Drug Resist; 2001; 7(2):165-70. PubMed ID: 11442342
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan.
Yan JJ; Wu HM; Huang AH; Fu HM; Lee CT; Wu JJ
J Clin Microbiol; 2000 Jul; 38(7):2475-9. PubMed ID: 10878028
[TBL] [Abstract][Full Text] [Related]
18. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and mechanism of resistance against macrolides and lincosamides in Streptococcus suis isolates.
Martel A; Baele M; Devriese LA; Goossens H; Wisselink HJ; Decostere A; Haesebrouck F
Vet Microbiol; 2001 Nov; 83(3):287-97. PubMed ID: 11574176
[TBL] [Abstract][Full Text] [Related]
20. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
